Advertisement
Screener

OrthoPediatrics Corp (KIDS) Investing Cash Flow

OrthoPediatrics Corp Investing Cash Flow

OrthoPediatrics Corp (KIDS) reported Investing Cash Flow of $1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05

  • OrthoPediatrics Corp net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $5.00M.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.79M.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$7.26M.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$26.84M.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for fiscal 2025 was -$43.63M.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for fiscal 2024 was -$13.16M, a 131.58% decline from fiscal 2023.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for fiscal 2023 was $41.68M.
  • OrthoPediatrics Corp net cash provided by (used in) investing activities for fiscal 2022 was -$113.37M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30$5.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.21M
10-Q · filed 2026-08-05
-$6.05M
derived: sum of 3 quarters · filed 2026-08-05
-$32.88M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$3.79M
10-Q · filed 2026-05-01
-$11.05M
derived: sum of 2 quarters · filed 2026-05-01
-$37.88M
derived: sum of 3 quarters · filed 2026-05-01
-$41.43M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$7.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
-$34.10M
derived: sum of 2 quarters · filed 2026-03-04
-$37.64M
derived: sum of 3 quarters · filed 2026-08-05
-$43.63M
10-K · filed 2026-03-04
2025-09-30-$26.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$30.38M
derived: sum of 2 quarters · filed 2026-08-05
-$36.37M
10-Q · filed 2025-10-29
-$38.78M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$3.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$9.53M
10-Q · filed 2026-08-05
-$11.94M
derived: sum of 3 quarters · filed 2026-08-05
-$38.71M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$5.99M
10-Q · filed 2026-05-01
-$8.40M
derived: sum of 2 quarters · filed 2026-05-01
-$35.17M
derived: sum of 3 quarters · filed 2026-05-01
-$15.47M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31-$2.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
-$29.18M
derived: sum of 2 quarters · filed 2026-03-04
-$9.48M
derived: sum of 3 quarters · filed 2026-03-04
-$13.16M
10-K · filed 2026-03-04
2024-09-30-$26.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$7.07M
derived: sum of 2 quarters · filed 2025-10-29
-$10.75M
10-Q · filed 2025-10-29
$7.17M
derived: sum of 4 quarters · filed 2026-03-04
2024-06-30$19.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$16.02M
10-Q · filed 2025-08-06
$33.94M
derived: sum of 3 quarters · filed 2026-03-04
$43.61M
derived: sum of 4 quarters · filed 2026-03-04
2024-03-31-$3.68M
10-Q · filed 2025-05-08
$14.24M
derived: sum of 2 quarters · filed 2026-03-04
$23.91M
derived: sum of 3 quarters · filed 2026-03-04
$5.69M
derived: sum of 4 quarters · filed 2026-03-04
2023-12-31$17.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$27.59M
derived: sum of 2 quarters · filed 2026-03-04
$9.37M
derived: sum of 3 quarters · filed 2026-03-04
$41.68M
10-K · filed 2026-03-04
2023-09-30$9.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$8.55M
derived: sum of 2 quarters · filed 2024-11-07
$23.75M
10-Q · filed 2024-11-07
$528.00K
derived: sum of 4 quarters · filed 2025-03-05
2023-06-30-$18.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$14.09M
10-Q · filed 2024-08-06
-$9.14M
derived: sum of 3 quarters · filed 2025-03-05
-$113.06M
derived: sum of 4 quarters · filed 2025-03-05
2023-03-31$32.31M
10-Q · filed 2024-05-07
$9.08M
derived: sum of 2 quarters · filed 2025-03-05
-$94.84M
derived: sum of 3 quarters · filed 2025-03-05
-$95.36M
derived: sum of 4 quarters · filed 2025-03-05
2022-12-31-$23.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
-$127.15M
derived: sum of 2 quarters · filed 2025-03-05
-$127.67M
derived: sum of 3 quarters · filed 2025-03-05
-$113.37M
10-K · filed 2025-03-05
2022-09-30-$103.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$104.45M
derived: sum of 2 quarters · filed 2023-11-07
-$90.14M
10-Q · filed 2023-11-07
-$87.18M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30-$528.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$13.78M
10-Q · filed 2023-08-01
$16.74M
derived: sum of 3 quarters · filed 2024-03-08
$13.70M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$14.30M
10-Q · filed 2023-05-02
$17.27M
derived: sum of 2 quarters · filed 2024-03-08
$14.22M
derived: sum of 3 quarters · filed 2024-03-08
$12.50M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$2.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$79.00K
derived: sum of 2 quarters · filed 2024-03-08
-$1.80M
derived: sum of 3 quarters · filed 2024-03-08
-$7.41M
10-K · filed 2024-03-08
2021-09-30-$3.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
-$4.77M
derived: sum of 2 quarters · filed 2022-11-01
-$10.38M
10-Q · filed 2022-11-01
-$69.43M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$1.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$7.33M
10-Q · filed 2022-08-04
-$66.39M
derived: sum of 3 quarters · filed 2023-03-01
-$67.68M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$5.61M
10-Q · filed 2022-05-05
-$64.66M
derived: sum of 2 quarters · filed 2023-03-01
-$65.95M
derived: sum of 3 quarters · filed 2023-03-01
-$69.68M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$59.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$60.34M
derived: sum of 2 quarters · filed 2023-03-01
-$64.07M
derived: sum of 3 quarters · filed 2023-03-01
-$69.69M
10-K · filed 2023-03-01
2020-09-30-$1.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$5.01M
derived: sum of 2 quarters · filed 2021-11-04
-$10.64M
10-Q · filed 2021-11-04
-$12.17M
derived: sum of 4 quarters · filed 2022-03-03
2020-06-30-$3.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$9.35M
10-Q · filed 2021-08-05
-$10.88M
derived: sum of 3 quarters · filed 2022-03-03
-$12.61M
derived: sum of 4 quarters · filed 2022-03-03
2020-03-31-$5.62M
10-Q · filed 2021-05-06
-$7.15M
derived: sum of 2 quarters · filed 2022-03-03
-$8.89M
derived: sum of 3 quarters · filed 2022-03-03
-$62.56M
derived: sum of 4 quarters · filed 2022-03-03
2019-12-31-$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$3.27M
derived: sum of 2 quarters · filed 2022-03-03
-$56.94M
derived: sum of 3 quarters · filed 2022-03-03
-$61.92M
10-K · filed 2022-03-03
2019-09-30-$1.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$55.41M
derived: sum of 2 quarters · filed 2020-11-05
-$60.39M
10-Q · filed 2020-11-05
-$60.85M
derived: sum of 4 quarters · filed 2021-03-11
2019-06-30-$53.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$58.66M
10-Q · filed 2020-08-06
-$59.12M
derived: sum of 3 quarters · filed 2021-03-11
-$60.27M
derived: sum of 4 quarters · filed 2021-03-11
2019-03-31-$4.98M
10-Q · filed 2020-05-06
-$5.44M
derived: sum of 2 quarters · filed 2021-03-11
-$6.60M
derived: sum of 3 quarters · filed 2021-03-11
-$8.02M
derived: sum of 4 quarters · filed 2021-03-11
2018-12-31-$459.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$1.62M
derived: sum of 2 quarters · filed 2021-03-11
-$3.04M
derived: sum of 3 quarters · filed 2021-03-11
-$5.96M
10-K · filed 2021-03-11
2018-09-30-$1.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$2.58M
derived: sum of 2 quarters · filed 2019-11-08
-$5.51M
10-Q · filed 2019-11-08
-$6.76M
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30-$1.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$4.35M
10-Q · filed 2019-08-13
-$5.61M
derived: sum of 3 quarters · filed 2020-03-05
-$7.75M
derived: sum of 4 quarters · filed 2020-03-05
2018-03-31-$2.93M
10-Q · filed 2019-05-09
-$4.19M
derived: sum of 2 quarters · filed 2020-03-05
-$6.33M
derived: sum of 3 quarters · filed 2020-03-05
-$7.84M
derived: sum of 4 quarters · filed 2020-03-05
2017-12-31-$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
-$3.40M
derived: sum of 2 quarters · filed 2020-03-05
-$4.91M
derived: sum of 3 quarters · filed 2020-03-05
-$6.54M
10-K · filed 2020-03-05
2017-09-30-$2.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
-$3.65M
derived: sum of 2 quarters · filed 2018-10-31
-$5.29M
10-Q · filed 2018-10-31
-$7.02M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30-$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$3.14M
10-Q · filed 2018-08-09
-$4.88M
derived: sum of 3 quarters · filed 2019-03-07
2017-03-31-$1.63M
10-Q · filed 2018-05-15
-$3.36M
derived: sum of 2 quarters · filed 2019-03-07
2016-12-31-$1.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
-$4.75M
10-K · filed 2019-03-07
2016-09-30-$3.02M
10-Q · filed 2017-11-13
2015-12-31-$1.71M
10-K · filed 2018-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
CARLSMED, INC. (CARL)United States$0.405B